CSI

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Equinix, Harbor Diversified, Altimmune, and UnitedHealth and Encourages Investors to Contact the Firm

Retrieved on: 
Giovedì, Maggio 30, 2024

For more information on the Harbor Diversified class action go to: https://bespc.com/cases/HRBR

Key Points: 
  • For more information on the Harbor Diversified class action go to: https://bespc.com/cases/HRBR
    Altimmune is a clinical stage biopharmaceutical company that focuses on developing treatments for obesity and liver diseases.
  • The Company's lead product candidate is pemvidutide, a glucagon-like peptide-1 ("GLP-1") agonist for the treatment of obesity and metabolic dysfunction-associated steatohepatitis ("MASH").
  • On January 6, 2021, UnitedHealth announced an agreement to acquire Change Healthcare (“Change”) and integrate it into its Optum business.
  • As a result of this disclosure, the price of UnitedHealth stock declined by $27 per share, erasing nearly $25 billion in shareholder value.

UNH INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that UnitedHealth Group Incorporated Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!

Retrieved on: 
Mercoledì, Maggio 29, 2024

NEW YORK, May 29, 2024 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against UnitedHealth Group Incorporated (“UnitedHealth Group” or “the Company”) (NYSE: UNH) and certain of its officers.

Key Points: 
  • NEW YORK, May 29, 2024 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against UnitedHealth Group Incorporated (“UnitedHealth Group” or “the Company”) (NYSE: UNH) and certain of its officers.
  • Such investors are encouraged to join this case by visiting the firm’s site: bgandg.com/UNH .
  • If you suffered a loss in UnitedHealth Group you have until July 15, 2024, to request that the Court appoint you as lead plaintiff.
  • Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits.

ROSEN, SKILLED INVESTOR COUNSEL, Encourages UnitedHealth Group Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - UNH

Retrieved on: 
Martedì, Maggio 28, 2024

WHAT TO DO NEXT: To join the UnitedHealth class action, go to https://rosenlegal.com/submit-form/?case_id=25195 or call Phillip Kim, Esq.

Key Points: 
  • WHAT TO DO NEXT: To join the UnitedHealth class action, go to https://rosenlegal.com/submit-form/?case_id=25195 or call Phillip Kim, Esq.
  • WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles.
  • The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation.
  • 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017.

UNITEDHEALTH GROUP INC. (NYSE: UNH) DEADLINE ALERT: Bernstein Liebhard LLP Reminds UnitedHealth Group Inc. Investors of Upcoming Deadline

Retrieved on: 
Martedì, Maggio 28, 2024

NEW YORK, May 28, 2024 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP:

Key Points: 
  • NEW YORK, May 28, 2024 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP:
    Do you, or did you, own shares of UnitedHealth Group Inc. (NYSE: UNH)?
  • If you purchased or acquired UnitedHealth common stock, and/or would like to discuss your legal rights and options please visit UnitedHealth Group Inc.
  • If you purchased or acquired UnitedHealth common stock, and/or would like to discuss your legal rights and options please visit UnitedHealth Group Inc.
  • The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414.

ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages UnitedHealth Group Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – UNH

Retrieved on: 
Martedì, Maggio 28, 2024

WHAT TO DO NEXT: To join the UnitedHealth class action, go to https://rosenlegal.com/submit-form/?case_id=25195 or call Phillip Kim, Esq.

Key Points: 
  • WHAT TO DO NEXT: To join the UnitedHealth class action, go to https://rosenlegal.com/submit-form/?case_id=25195 or call Phillip Kim, Esq.
  • WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles.
  • The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation.
  • 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017.

UNH Stockholder Reminder: Contact Robbins LLP for Information About the UnitedHealth Group, Inc. Class Action

Retrieved on: 
Martedì, Maggio 28, 2024

UnitedHealth is a health care and well-being company comprised of two distinct and complementary businesses: Optum and UnitedHealthcare.

Key Points: 
  • UnitedHealth is a health care and well-being company comprised of two distinct and complementary businesses: Optum and UnitedHealthcare.
  • For more information, submit a form , email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003.
  • The Allegations: Robbins LLP is Investigating Allegations that UnitedHealth Group, Inc. (UNH) Failed to Disclose DOJ Investigation
    According to the complaint, on January 6, 2021, UnitedHealth announced an agreement to acquire Change Healthcare (“Change”) and integrate it into its existing Optum business.
  • In response, on February 24, 2022, the U.S. Department of Justice (“DOJ”) filed a lawsuit challenging UnitedHealth’s acquisition of Change.

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Equinix, Harbor Diversified, Altimmune, and UnitedHealth and Encourages Investors to Contact the Firm

Retrieved on: 
Domenica, Maggio 26, 2024

For more information on the Harbor Diversified class action go to: https://bespc.com/cases/HRBR

Key Points: 
  • For more information on the Harbor Diversified class action go to: https://bespc.com/cases/HRBR
    Altimmune is a clinical stage biopharmaceutical company that focuses on developing treatments for obesity and liver diseases.
  • The Company's lead product candidate is pemvidutide, a glucagon-like peptide-1 ("GLP-1") agonist for the treatment of obesity and metabolic dysfunction-associated steatohepatitis ("MASH").
  • On January 6, 2021, UnitedHealth announced an agreement to acquire Change Healthcare (“Change”) and integrate it into its Optum business.
  • As a result of this disclosure, the price of UnitedHealth stock declined by $27 per share, erasing nearly $25 billion in shareholder value.

INVESTOR ALERT: DiCello Levitt LLP Announces Shareholder Class Action Against UnitedHealth Group Inc. (NYSE: UNH); Investors with Losses Encouraged to Seek Counsel

Retrieved on: 
Venerdì, Maggio 24, 2024

UnitedHealth investors have until July 15 to seek appointment as lead plaintiff of the class action lawsuit.

Key Points: 
  • UnitedHealth investors have until July 15 to seek appointment as lead plaintiff of the class action lawsuit.
  • Until a case is filed and a class is certified, you are not represented by counsel unless you retain one.
  • The UnitedHealth class action lawsuit alleges that on January 6, 2021, UnitedHealth announced an agreement to acquire Change Healthcare (“Change”) and integrate it into its existing Optum business.
  • Yet, rather than disclosing this material investigation to investors or the public, UnitedHealth insiders instead sold more than $120 million worth of their UnitedHealth shares.

ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages UnitedHealth Group Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – UNH

Retrieved on: 
Mercoledì, Maggio 22, 2024

WHAT TO DO NEXT: To join the UnitedHealth class action, go to https://rosenlegal.com/submit-form/?case_id=25195 or call Phillip Kim, Esq.

Key Points: 
  • WHAT TO DO NEXT: To join the UnitedHealth class action, go to https://rosenlegal.com/submit-form/?case_id=25195 or call Phillip Kim, Esq.
  • WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles.
  • The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation.
  • 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017.

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against UnitedHealth, and Vestis and Encourages Investors to Contact the Firm

Retrieved on: 
Mercoledì, Maggio 22, 2024

UnitedHealth is an American multinational health insurance and services company comprised of two distinct and complementary businesses: Optum and UnitedHealthcare.

Key Points: 
  • UnitedHealth is an American multinational health insurance and services company comprised of two distinct and complementary businesses: Optum and UnitedHealthcare.
  • UnitedHealthcare provides health insurance to individuals, employers, and small businesses and is the largest insurance provider in the United States.
  • On January 6, 2021, UnitedHealth announced an agreement to acquire Change Healthcare (“Change”) and integrate it into its Optum business.
  • For more information on the Vestis class action go to: https://bespc.com/cases/VSTS